Omeros (OMER) Assets Average (2011 - 2026)
Omeros (OMER) reported Assets Average of $305.9 million for Q1 2026, up 19.44% on a YoY basis from $256.1 million in Q1 2025, and up 19.65% sequentially from $255.7 million in Q4 2025.
Omeros (OMER) Assets Average (2011 - 2026) Analysis & Trends
Omeros (OMER) has 16 years of Assets Average data on file, last reported at $305.9 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 19.44% year-over-year to $305.9 million; the trailing twelve-month figure through Mar 2026 stood at $305.9 million (up 19.44% YoY), and the FY2025 full-year result was $301.4 million, down 8.03% from the prior year.
- Assets Average rose to $305.9 million in Q1 2026, from $255.7 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $575.6 million in Q1 2023 to a low of $193.1 million in Q3 2025.
- A 5-year average of $376.8 million and a median of $394.3 million in 2022 frame the typical range for Assets Average.
- Across the five-year window, Assets Average jumped 198.78% in 2022 and tumbled 45.11% in 2025, its largest moves.
- Tracing OMER's Assets Average over 5 years: stood at $524.3 million in 2022, then declined by 16.9% to $435.7 million in 2023, then tumbled by 32.24% to $295.2 million in 2024, then decreased by 13.39% to $255.7 million in 2025, then climbed by 19.65% to $305.9 million in 2026.
- Business Quant data shows OMER's Assets Average at $305.9 million in Q1 2026, $255.7 million in Q4 2025, and $193.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | 305.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305.90 Mn |
| Dec 31, 2025 | 255.67 Mn |
| Sep 30, 2025 | 193.14 Mn |
| Jun 30, 2025 | 217.87 Mn |
| Mar 31, 2025 | 256.12 Mn |
| Dec 31, 2024 | 295.21 Mn |
| Sep 30, 2024 | 334.82 Mn |
| Jun 30, 2024 | 396.90 Mn |
| Mar 31, 2024 | 407.88 Mn |
| Dec 31, 2023 | 435.67 Mn |
| Sep 30, 2023 | 510.25 Mn |
| Jun 30, 2023 | 543.78 Mn |
| Mar 31, 2023 | 575.55 Mn |
| Dec 31, 2022 | 524.26 Mn |
| Sep 30, 2022 | 401.59 Mn |
| Jun 30, 2022 | 357.45 Mn |
| Mar 31, 2022 | 394.27 Mn |
| Dec 31, 2021 | 271.35 Mn |
| Sep 30, 2021 | 134.41 Mn |
| Jun 30, 2021 | 153.42 Mn |